Drugs called antivirals treat hepatitis C. The latest medication to receive approval from the FDA is glecaprevir and pibrentasvir (Mavyret), a daily pill that offers a shorter treatment cycle of 8 weeks for adult patients with all types of HCV who don’t have cirrhosis and who have not been previously treated. The length of treatment is longer for those who are in a different disease stage. Zepatier, which combines elbasvir and grazoprevir, and Harvoni, which combines sofosbuvir and ledipasvir, are once-daily pills that are indicated for people with only certain types of HCV. Both have been found to cure the disease in most people in 8-12 weeks. Another once a day medicine is Vosevi. This is a combination of sofosbuvir, velpatasvir, and voxilaprevir that has been approved to treat adults with chronic HCV either with no cirrhosis or with compensated cirrhosis who have already had certain treatments. Additional treatment options include daclatasvir (Daklinza), ombitasvir-paritaprevir-ritonavir (Technivie), ombitasvir-paritaprevir-ritonavir-dasabuvir (Viekira Pak), peginterferon, sofosbuvir (Solvadi), and/or ribavirin (Rebetol). Some of these must be combined to be effective. Ask your doctor what's best for you, based on the type of HCV you have, your medical needs and insurance coverage, since these medications are pricey.